Phil Tennant serves as the Chief Commercial Officer at PRECIGEN INC, a biotechnology company focused on developing innovative therapies and products through its proprietary precision technology platforms. With a robust background in the life sciences industry, Tennant has been instrumental in steering the commercial strategy and growth of PRECIGEN INC. His role involves overseeing the commercialization of the company's diverse product pipeline, ensuring that innovative solutions reach the market efficiently and effectively. Prior to joining PRECIGEN INC, Tennant held several leadership positions in the biotechnology and pharmaceutical sectors. He has a proven track record of driving business development and fostering strategic partnerships that have significantly contributed to the growth and success of previous organizations. His expertise in navigating the complex landscape of biotech commercialization has been a key asset to PRECIGEN INC, enabling the company to expand its reach and impact in the industry. Tennant's strategic vision and dedication to advancing healthcare solutions continue to drive PRECIGEN INC's mission to transform medicine through precision technology.